Patient Reported Outcomes in Early Arthritis Patients

Pathophysiology and treatment of rheumatic disease

Patient Reported Outcomes in Early Arthritis Patients

Pathophysiology and treatment of rheumatic disease

LOW DISEASE ACTIVITY OR DAS-REMISSION AS TREATMENT TARGET IN EARLY RHEUMATOID ARTHRITIS PATIENTS

Pathophysiology and treatment of rheumatic disease

Clinical and Radiological Outcomes Of Two Years Remission Steered Treatment In Early Arthritis Patients

Pathophysiology and treatment of rheumatic disease

Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis

Pathophysiology and treatment of rheumatic disease

OUTCOMES OF TWO YEARS OF REMISSION STEERED TREATMENT IN EARLY ARTHRITIS PATIENTS

Pathophysiology and treatment of rheumatic disease

Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis

Pathophysiology and treatment of rheumatic disease

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

__Objective__ In this study we aimed to evaluate the effect of lowering the cut point of the 2010 criteria to identify more patients with RA among early inflammatory arthritis patients. __Methods__ We included early arthritis patients from the Rotterdam Early Arthritis Cohort with at least one joint with clinical synovitis and symptoms for <1 year, with no other explanation for their symptoms. The demographic and clinical characteristics of each patient were recorded at baseline. Patients were classified as case or non-case at the 1-year follow-up by the definition used in the development of the 2010 criteria (MTX initiati